remibrutinib
novartis
['remibrutinib', '#1113']
#acr22 plenary ii. abstr#1113 promising news in #sjogren. phase 2 rct showed oral btk-i remibrutinib improved essdai score vs placebo (delta -2.8) &amp; salivary flow at wks 24. esspri unchanged. no major safety concern. look forward to phase 3 results soon #acrbest 
Rheumatologist. Interested in B-cells, Lupus, Sjogren, Pre-Connective Tissue Disease, Tennis, Running & Travelling ??